One of China’s best-known robot makers — Unitree Robotics of Hangzhou — has entered the final stage of its initial public offering (IPO) on the Shanghai Stock Exchange, on its technology board, the STAR Market. The offering formally launched on July 31, 2026, and the company intends to raise roughly 4.2 billion yuan — approximately $620 million. This is one of the most notable technology IPOs of the year in China and a symbolic moment for the entire humanoid-robotics industry, which over the past two years has gone from a niche to one of the hottest investment themes on global markets.
(Clarification: some earlier framings mentioned a figure of “nearly $900 million” — this is not confirmed. Confirmed data from Caixin, Xinhua, and the Shanghai exchange itself point to roughly $620 million / 4.2 billion yuan.)
Unitree is known primarily for two product lines. The first is quadruped robots, a kind of “robot dog” that the company sold for years at prices significantly below competing products, which is exactly how it won popularity among researchers, universities, and enthusiasts. The second, strategically more important line, is humanoid robots, which now account for roughly 52% of the company’s revenue. It is the humanoids that became the driver that propelled Unitree into the ranks of the stars of China’s technology sector and drew investors’ attention ahead of the IPO.
The company’s financial figures explain the excitement. In 2025, Unitree’s revenue reached roughly 1.7 billion yuan, and the growth rates over the preceding years were striking — a compound annual growth rate (CAGR) of about 227%. Core net profit was roughly 591 million yuan, and the gross margin held at around 60% — extraordinarily high for a hardware business. The company’s valuation within the IPO came to roughly 42 billion yuan (approximately $6.2 billion). It is worth noting, however, one note of caution: in the first half of 2026, revenue growth reportedly slowed to roughly 40% — a reminder that even the hottest sectors cannot sustain triple-digit growth indefinitely.
The speed of the IPO’s approval deserves separate attention. The Shanghai exchange’s listing committee reviewed Unitree’s application on June 1, 2026, and by early July the company had received approval. The entire process took about 104 days — record-fast by STAR Market standards, where reviews usually take considerably longer. Such swiftness is itself a signal: the Chinese regulator and the exchange are interested in bringing national champions in robotics — a field Beijing regards as a strategic priority — to the public market. The subscription and the listing itself were scheduled for around August 10, 2026.
The broader context makes this IPO even more significant. Robotics, and especially humanoid robots, became one of the central themes of technology investment in 2025–2026 — partly thanks to progress in artificial intelligence, which gave robots far better “brains” for navigating the physical world. China has bet on this sector as a way to simultaneously answer demographic challenges (an aging population, labor shortages) and cement technological leadership. Unitree is the flagship in this picture, a company often cited as an example that Chinese manufacturers can offer advanced humanoids at prices unattainable for Western competitors.
For investors, the Unitree IPO is at once an opportunity and a risk. On one hand, the company is profitable, growing rapidly, and operating in a sector with enormous potential. On the other, a valuation of $6.2 billion bakes in very high expectations of future growth, and the slowdown in the first half of 2026 is a reminder that the humanoid market is still young and its real size is a matter of debate. The success of the STAR Market listing will also carry meaning far beyond the company itself: it will serve as a barometer of Chinese investors’ appetite for robotics assets and, possibly, open the path to public offerings for other players in the sector.
Ultimately, Unitree’s listing is also a geopolitical signal. At a time when the U.S. and China are competing for leadership in advanced technologies, the arrival on the public market of a profitable Chinese maker of humanoid robots demonstrates how seriously Beijing takes this industry. Regardless of how the shares behave after the listing, the very fact of a fast, well-prepared IPO by a company of this profile underscores that the race for the future of robotics has long moved beyond the labs and onto the financial markets.
Unitree’s own story is telling for understanding how China managed to break into robotics leadership. The company was founded by Wang Xingxing, an engineer who became interested in creating affordable quadruped robots while still a student. The key to success was precisely the pricing strategy: where Western analogs such as Boston Dynamics products cost tens or hundreds of thousands of dollars, Unitree offered functionally comparable machines at a fraction of that price. This opened the market to universities, research labs, and enthusiasts around the world, and Unitree’s robots became viral heroes of numerous videos — from dance performances to demonstrations of acrobatics. That scale of recognition turned the company into a kind of face of the Chinese robotics industry long before the IPO.
The broader strategic context is the global race for humanoid robots, in which Unitree competes not only with Chinese firms but also with such projects as Tesla’s Optimus and the robots of the startup Figure. Beijing has openly designated robotics and “embodied AI” as strategic priorities, seeing in them an answer to several challenges at once: an aging population, rising labor costs, and the need to cement technological leadership in a field closely tied to artificial intelligence. In this light, Unitree’s fast and well-prepared IPO on the STAR Market — created precisely to support national technology champions — becomes not only a financial but also a political event. A successful listing could attract a new wave of capital into Chinese robotics and serve as a signal to other companies in the sector that the public market is ready to finance their ambitions. At the same time, it will be a test of whether investors are ready to pay premium valuations for an industry whose real volumes are still taking shape.
Risks that accompany such offerings must also be taken into account. After a hyped listing, the shares of young technology companies often experience bursts of volatility, and the end of lock-up periods — when early investors gain the right to sell their stakes — can create pressure on the quotes. In addition, a geopolitical dimension hangs over the sector: American regulators are looking ever more closely at Chinese companies in areas they consider sensitive, and robotics, with its dual — civilian and potentially military — application, may well come under such scrutiny. This could limit Unitree’s access to Western markets or technologies in the future. Despite these risks, the very fact of a fast, well-prepared, and profitable IPO by a company of this profile remains an important milestone — both for Unitree itself and for the entire Chinese humanoid-robotics industry, which has gone from a niche direction to one of the defining technology bets of the decade.
Sources: Caixin, Xinhua, Shanghai Stock Exchange (SSE), TechNode (May–July 2026).
